Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 490

1.

The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials.

Sanyal AJ, Harrison SA, Ratziu V, Abdelmalek MF, Diehl AM, Caldwell S, Shiffman ML, Aguilar Schall R, Jia C, McColgan B, Djedjos CS, McHutchison JG, Subramanian GM, Myers RP, Younossi Z, Muir AJ, Afdhal NH, Bosch J, Goodman Z.

Hepatology. 2019 Apr 16. doi: 10.1002/hep.30664. [Epub ahead of print]

PMID:
30993748
2.

Coagulation in Cirrhosis.

O'Leary JG, Greenberg CS, Patton HM, Caldwell SH.

Gastroenterology. 2019 Apr 12. pii: S0016-5085(19)35694-X. doi: 10.1053/j.gastro.2019.03.070. [Epub ahead of print] Review.

PMID:
30986390
3.

Acute kidney injury is associated with low factor XIII in decompensated cirrhosis.

Intagliata NM, Davis JPE, Lafond J, Erdbruegger U, Greenberg CS, Northup PG, Caldwell SH.

Dig Liver Dis. 2019 Apr 6. pii: S1590-8658(19)30494-3. doi: 10.1016/j.dld.2019.03.011. [Epub ahead of print]

PMID:
30967339
4.

The Planning, Implementation, and Evaluation of California's Inaugural Food Waste Prevention Week.

Gosliner W, Delaney T, Caldwell S, Lee JM, Billups N, Floor S.

J Public Health Manag Pract. 2019 Feb 14. doi: 10.1097/PHH.0000000000000896. [Epub ahead of print]

PMID:
30789587
5.

Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis.

Intagliata NM, Caldwell SH, Tripodi A.

Gastroenterology. 2019 May;156(6):1582-1599.e1. doi: 10.1053/j.gastro.2019.01.265. Epub 2019 Feb 13. Review.

PMID:
30771355
6.

Selective mitochondrial superoxide generation in vivo is cardioprotective through hormesis.

Antonucci S, Mulvey JF, Burger N, Di Sante M, Hall AR, Hinchy EC, Caldwell ST, Gruszczyk AV, Deshwal S, Hartley RC, Kaludercic N, Murphy MP, Di Lisa F, Krieg T.

Free Radic Biol Med. 2019 Feb 4;134:678-687. doi: 10.1016/j.freeradbiomed.2019.01.034. [Epub ahead of print]

7.

Balloon Retrograde Transvenous Obliteration Versus Endoscopic Cyanoacrylate in Bleeding Gastric Varices: Comparison of Rebleeding and Mortality with Extended Follow-up.

Stein DJ, Salinas C, Sabri S, Onyeali R, Caldwell S, Henry Z.

J Vasc Interv Radiol. 2019 Feb;30(2):187-194. doi: 10.1016/j.jvir.2018.12.008.

PMID:
30717949
8.

Selective Disruption of Mitochondrial Thiol Redox State in Cells and In Vivo.

Booty LM, Gawel JM, Cvetko F, Caldwell ST, Hall AR, Mulvey JF, James AM, Hinchy EC, Prime TA, Arndt S, Beninca C, Bright TP, Clatworthy MR, Ferdinand JR, Prag HA, Logan A, Prudent J, Krieg T, Hartley RC, Murphy MP.

Cell Chem Biol. 2019 Mar 21;26(3):449-461.e8. doi: 10.1016/j.chembiol.2018.12.002. Epub 2019 Jan 31.

9.

Relative information from thermal infrared imagery via unoccupied aerial vehicle informs simulations and spatially-distributed assessments of stream temperature.

Caldwell SH, Kelleher C, Baker EA, Lautz LK.

Sci Total Environ. 2019 Apr 15;661:364-374. doi: 10.1016/j.scitotenv.2018.12.457. Epub 2019 Jan 3.

PMID:
30677682
10.

The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.

Trauner M, Gulamhusein A, Hameed B, Caldwell S, Shiffman ML, Landis C, Eksteen B, Agarwal K, Muir A, Rushbrook S, Lu X, Xu J, Chuang JC, Billin AN, Li G, Chung C, Subramanian GM, Myers RP, Bowlus CL, Kowdley KV.

Hepatology. 2019 Jan 19. doi: 10.1002/hep.30509. [Epub ahead of print]

PMID:
30661255
11.

Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients.

Violi F, Corazza GR, Caldwell SH, Talerico G, Romiti GF, Napoleone L, Perticone F, Bolondi L, Pietrangelo A, Vestri AR, Raparelli V, Basili S; PRO-LIVER Collaborative Group.

Thromb Haemost. 2019 Mar;119(3):496-499. doi: 10.1055/s-0038-1676981. Epub 2019 Jan 7.

PMID:
30616246
12.

Coagulation Pathways, Hemostasis, and Thrombosis in Liver Failure.

Intagliata NM, Davis JPE, Caldwell SH.

Semin Respir Crit Care Med. 2018 Oct;39(5):598-608. doi: 10.1055/s-0038-1673658. Epub 2018 Nov 28. Review.

PMID:
30485890
13.

Patient-Directed Music Therapy in the ICU.

Bamikole PO, Theriault BM, Caldwell SL, Schlesinger JJ.

Crit Care Med. 2018 Nov;46(11):e1085. doi: 10.1097/CCM.0000000000003365. No abstract available.

PMID:
30312244
14.

Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.

Jayakumar S, Middleton MS, Lawitz EJ, Mantry PS, Caldwell SH, Arnold H, Mae Diehl A, Ghalib R, Elkhashab M, Abdelmalek MF, Kowdley KV, Stephen Djedjos C, Xu R, Han L, Mani Subramanian G, Myers RP, Goodman ZD, Afdhal NH, Charlton MR, Sirlin CB, Loomba R.

J Hepatol. 2019 Jan;70(1):133-141. doi: 10.1016/j.jhep.2018.09.024. Epub 2018 Oct 4.

15.

Serial MRI Imaging Reveals Minimal Impact of Ketogenic Diet on Established Liver Tumor Growth.

Byrne FL, Hargett SR, Lahiri S, Roy RJ, Berr SS, Caldwell SH, Hoehn KL.

Cancers (Basel). 2018 Sep 5;10(9). pii: E312. doi: 10.3390/cancers10090312.

16.

Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease.

Muir AJ, Levy C, Janssen HLA, Montano-Loza AJ, Shiffman ML, Caldwell S, Luketic V, Ding D, Jia C, McColgan BJ, McHutchison JG, Mani Subramanian G, Myers RP, Manns M, Chapman R, Afdhal NH, Goodman Z, Eksteen B, Bowlus CL; GS-US-321-0102 Investigators.

Hepatology. 2019 Feb;69(2):684-698. doi: 10.1002/hep.30237. Epub 2019 Jan 11.

PMID:
30153359
17.

The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options.

Younossi Z, Stepanova M, Sanyal AJ, Harrison SA, Ratziu V, Abdelmalek MF, Diehl AM, Caldwell S, Shiffman ML, Schall RA, McColgan B, Subramanian GM, Myers RP, Muir A, Afdhal NH, Bosch J, Goodman Z.

J Hepatol. 2018 Dec;69(6):1365-1370. doi: 10.1016/j.jhep.2018.08.013. Epub 2018 Aug 23.

PMID:
30144554
18.

Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases.

Stine JG, Wentworth BJ, Zimmet A, Rinella ME, Loomba R, Caldwell SH, Argo CK.

Aliment Pharmacol Ther. 2018 Oct;48(7):696-703. doi: 10.1111/apt.14937. Epub 2018 Aug 22. Review.

PMID:
30136293
19.

Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference.

Intagliata NM, Argo CK, Stine JG, Lisman T, Caldwell SH, Violi F; faculty of the 7th International Coagulation in Liver Disease.

Thromb Haemost. 2018 Aug;118(8):1491-1506. doi: 10.1055/s-0038-1666861. Epub 2018 Jul 30. No abstract available.

20.

Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis.

Harrison SA, Abdelmalek MF, Caldwell S, Shiffman ML, Diehl AM, Ghalib R, Lawitz EJ, Rockey DC, Schall RA, Jia C, McColgan BJ, McHutchison JG, Subramanian GM, Myers RP, Younossi Z, Ratziu V, Muir AJ, Afdhal NH, Goodman Z, Bosch J, Sanyal AJ; GS-US-321-0105 and GS-US-321-0106 Investigators.

Gastroenterology. 2018 Oct;155(4):1140-1153. doi: 10.1053/j.gastro.2018.07.006. Epub 2018 Jul 7.

PMID:
29990488
21.

Gastric Antral Vascular Ectasia Pathogenesis and the Link to the Metabolic Syndrome.

Smith E, Davis J, Caldwell S.

Curr Gastroenterol Rep. 2018 Jul 2;20(8):36. doi: 10.1007/s11894-018-0644-7. Review.

PMID:
29961911
22.

The Relationship Between the Supervisory Working Alliance and Student Self-Efficacy in Genetic Counseling Training.

Caldwell S, Wusik K, He H, Yager G, Atzinger C.

J Genet Couns. 2018 Jun 22. doi: 10.1007/s10897-018-0263-3. [Epub ahead of print]

PMID:
29934760
23.

Physical deconditioning is the common denominator in both obese and overweight subjects with nonalcoholic steatohepatitis.

Argo CK, Stine JG, Henry ZH, Lackner C, Patrie JT, Weltman AL, Caldwell SH.

Aliment Pharmacol Ther. 2018 Aug;48(3):290-299. doi: 10.1111/apt.14803. Epub 2018 May 24.

PMID:
29797529
24.

Thrombosis of the Portal Venous System in Cirrhotic vs. Non-Cirrhotic Patients.

Cruz-Ramón V, Chinchilla-López P, Ramírez-Pérez O, Aguilar-Olivos NE, Alva-López LF, Fajardo-Ordoñez E, Ponciano-Rodríguez G, Northup PG, Intagliata N, Caldwell SH, Qi X, Méndez-Sánchez N.

Ann Hepatol. 2018 May-June;17(3):476-481. doi: 10.5604/01.3001.0011.7392. Epub 2018 Apr 9.

25.

Plasticity of Aminoglycoside Binding to Antibiotic Kinase APH(2″)-Ia.

Caldwell SJ, Berghuis AM.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00202-18. doi: 10.1128/AAC.00202-18. Print 2018 Jul.

26.

Mitochondrial oxidative stress causes insulin resistance without disrupting oxidative phosphorylation.

Fazakerley DJ, Minard AY, Krycer JR, Thomas KC, Stöckli J, Harney DJ, Burchfield JG, Maghzal GJ, Caldwell ST, Hartley RC, Stocker R, Murphy MP, James DE.

J Biol Chem. 2018 May 11;293(19):7315-7328. doi: 10.1074/jbc.RA117.001254. Epub 2018 Mar 29.

27.

Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1.

Mills EL, Ryan DG, Prag HA, Dikovskaya D, Menon D, Zaslona Z, Jedrychowski MP, Costa ASH, Higgins M, Hams E, Szpyt J, Runtsch MC, King MS, McGouran JF, Fischer R, Kessler BM, McGettrick AF, Hughes MM, Carroll RG, Booty LM, Knatko EV, Meakin PJ, Ashford MLJ, Modis LK, Brunori G, Sévin DC, Fallon PG, Caldwell ST, Kunji ERS, Chouchani ET, Frezza C, Dinkova-Kostova AT, Hartley RC, Murphy MP, O'Neill LA.

Nature. 2018 Apr 5;556(7699):113-117. doi: 10.1038/nature25986. Epub 2018 Mar 28.

28.

Development and Validation of the Genetic Counseling Self-Efficacy Scale (GCSES).

Caldwell S, Wusik K, He H, Yager G, Atzinger C.

J Genet Couns. 2018 Sep;27(5):1248-1257. doi: 10.1007/s10897-018-0249-1. Epub 2018 Mar 18.

PMID:
29550972
29.

Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis.

Stine JG, Niccum BA, Zimmet AN, Intagliata N, Caldwell SH, Argo CK, Northup PG.

Clin Transl Gastroenterol. 2018 Mar 6;9(3):140. doi: 10.1038/s41424-018-0002-y.

30.

Treatment of Type-1 Hepatorenal Syndrome with Pentoxifylline: A Randomized Placebo Controlled Clinical Trial.

Stine JG, Wang J, Cornella SL, Behm BW, Henry Z, Shah NL, Caldwell SH, Northup PG.

Ann Hepatol. 2018 Mar 1;17(2):300-306. doi: 10.5604/01.3001.0010.8660.

31.

Viscoelastic Testing in Liver Disease.

Davis JPE, Northup PG, Caldwell SH, Intagliata NM.

Ann Hepatol. 2018 Mar 1;17(2):205-213. doi: 10.5604/01.3001.0010.8635.

32.

Demonstration of universal parametric entangling gates on a multi-qubit lattice.

Reagor M, Osborn CB, Tezak N, Staley A, Prawiroatmodjo G, Scheer M, Alidoust N, Sete EA, Didier N, da Silva MP, Acala E, Angeles J, Bestwick A, Block M, Bloom B, Bradley A, Bui C, Caldwell S, Capelluto L, Chilcott R, Cordova J, Crossman G, Curtis M, Deshpande S, El Bouayadi T, Girshovich D, Hong S, Hudson A, Karalekas P, Kuang K, Lenihan M, Manenti R, Manning T, Marshall J, Mohan Y, O'Brien W, Otterbach J, Papageorge A, Paquette JP, Pelstring M, Polloreno A, Rawat V, Ryan CA, Renzas R, Rubin N, Russel D, Rust M, Scarabelli D, Selvanayagam M, Sinclair R, Smith R, Suska M, To TW, Vahidpour M, Vodrahalli N, Whyland T, Yadav K, Zeng W, Rigetti CT.

Sci Adv. 2018 Feb 2;4(2):eaao3603. doi: 10.1126/sciadv.aao3603. eCollection 2018 Feb.

33.

Methionine sulfoxide reductase B3 requires resolving cysteine residues for full activity and can act as a stereospecific methionine oxidase.

Cao Z, Mitchell L, Hsia O, Scarpa M, Caldwell ST, Alfred AD, Gennaris A, Collet JF, Hartley RC, Bulleid NJ.

Biochem J. 2018 Feb 28;475(4):827-838. doi: 10.1042/BCJ20170929.

34.

DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis.

Loomba R, Gindin Y, Jiang Z, Lawitz E, Caldwell S, Djedjos CS, Xu R, Chung C, Myers RP, Subramanian GM, Goodman Z, Charlton M, Afdhal NH, Diehl AM.

JCI Insight. 2018 Jan 25;3(2). pii: 96685. doi: 10.1172/jci.insight.96685. eCollection 2018 Jan 25.

35.

Thrombosis of the Portal Venous System in Cirrhotic vs. Non-Cirrhotic Patients.

Cruz-Ramón V, Chinchilla-López P, Ramírez-Pérez O, Aguilar-Olivos NE, Alva-López LF, Fajardo-Ordoñez E, Ponciano-Rodríguez G, Northup PG, Intagliata N, Caldwell SH, Qi X, Méndez-Sánchez N.

Ann Hepatol. 2018 May - Jun;17(3):476-481. doi: 10.5604/01.3001.0011.7392.

36.

Treatment of Type-1 Hepatorenal Syndrome with Pentoxifylline: A Randomized Placebo Controlled Clinical Trial.

Stine JG, Wang J, Cornella SL, Behm BW, Henry Z, Shah NL, Caldwell SH, Northup PG.

Ann Hepatol. 2018 Mar - Apr;17(2):300-306. doi: 10.5604/01.3001.0010.8661.

37.

Viscoelastic Testing in Liver Disease.

Davis JPE, Northup PG, Caldwell SH, Intagliata NM.

Ann Hepatol. 2018 Mar - Apr;17(2):205-213. doi: 10.5604/01.3001.0010.8635.

38.

Building a culture of life by embracing the feminine genius: A message to Catholic women in health care.

Caldwell S.

Linacre Q. 2017 Nov;84(4):403-406. doi: 10.1080/00243639.2017.1381011. Epub 2017 Nov 8.

39.

Cryptogenic vs. NASH-cirrhosis: The rose exists well before its name....

Caldwell S, Marchesini G.

J Hepatol. 2018 Mar;68(3):391-392. doi: 10.1016/j.jhep.2017.12.006. Epub 2017 Dec 13. No abstract available.

PMID:
29247726
40.

Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.

Younossi ZM, Loomba R, Anstee QM, Rinella ME, Bugianesi E, Marchesini G, Neuschwander-Tetri BA, Serfaty L, Negro F, Caldwell SH, Ratziu V, Corey KE, Friedman SL, Abdelmalek MF, Harrison SA, Sanyal AJ, Lavine JE, Mathurin P, Charlton MR, Goodman ZD, Chalasani NP, Kowdley KV, George J, Lindor K.

Hepatology. 2018 Jul;68(1):349-360. doi: 10.1002/hep.29721.

41.

Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Younossi ZM, Loomba R, Rinella ME, Bugianesi E, Marchesini G, Neuschwander-Tetri BA, Serfaty L, Negro F, Caldwell SH, Ratziu V, Corey KE, Friedman SL, Abdelmalek MF, Harrison SA, Sanyal AJ, Lavine JE, Mathurin P, Charlton MR, Chalasani NP, Anstee QM, Kowdley KV, George J, Goodman ZD, Lindor K.

Hepatology. 2018 Jul;68(1):361-371. doi: 10.1002/hep.29724.

42.

Changes in hemostasis in liver disease.

Intagliata NM, Caldwell SH.

J Hepatol. 2017 Dec;67(6):1332-1333. doi: 10.1016/j.jhep.2017.07.001. No abstract available.

PMID:
29156209
43.

The Reply.

Smith EZ, Caldwell SH.

Am J Med. 2017 Nov;130(11):e513. doi: 10.1016/j.amjmed.2017.08.007. No abstract available.

PMID:
29073975
44.

The Optimal Transfusion Strategy in Liver Transplantation: The Quest Continues.

Intagliata NM, Northup PG, Caldwell SH.

Ann Hepatol. 2017 November-December,;16(6):828-829. doi: 10.5604/01.3001.0010.5270. No abstract available.

45.

Functional Analysis of Phagocyte Activity in Whole Blood from HIV/Tuberculosis-Infected Individuals Using a Novel Flow Cytometry-Based Assay.

Gupta-Wright A, Tembo D, Jambo KC, Chimbayo E, Mvaya L, Caldwell S, Russell DG, Mwandumba HC.

Front Immunol. 2017 Sep 28;8:1222. doi: 10.3389/fimmu.2017.01222. eCollection 2017.

46.

Unusual presentation of long-lost inferior vena cava filter.

Davis N, MacCormick AD, Caldwell S.

ANZ J Surg. 2018 Mar;88(3):238-239. doi: 10.1111/ans.14219. Epub 2017 Oct 5. No abstract available.

PMID:
28982214
47.

The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial.

Loomba R, Lawitz E, Mantry PS, Jayakumar S, Caldwell SH, Arnold H, Diehl AM, Djedjos CS, Han L, Myers RP, Subramanian GM, McHutchison JG, Goodman ZD, Afdhal NH, Charlton MR; GS-US-384-1497 Investigators.

Hepatology. 2017 Sep 11. doi: 10.1002/hep.29514. [Epub ahead of print] Erratum in: Hepatology. 2018 May;67(5):2063.

48.

MitoNeoD: A Mitochondria-Targeted Superoxide Probe.

Shchepinova MM, Cairns AG, Prime TA, Logan A, James AM, Hall AR, Vidoni S, Arndt S, Caldwell ST, Prag HA, Pell VR, Krieg T, Mulvey JF, Yadav P, Cobley JN, Bright TP, Senn HM, Anderson RF, Murphy MP, Hartley RC.

Cell Chem Biol. 2017 Oct 19;24(10):1285-1298.e12. doi: 10.1016/j.chembiol.2017.08.003. Epub 2017 Sep 7.

49.

Editorial: Severe Acute Liver Injury: Cause Connects to Outcome.

Argo CK, Caldwell SH.

Am J Gastroenterol. 2017 Sep;112(9):1397-1399. doi: 10.1038/ajg.2017.221.

PMID:
28874859
50.

Reply to: "Re: Bleeding Risk and Management in Interventional Procedures in Chronic Liver Disease".

DeAngelis GA, Khot R, Haskal ZJ, Maitland HS, Northup PG, Shah NL, Caldwell SH.

J Vasc Interv Radiol. 2017 Sep;28(9):1337-1338. doi: 10.1016/j.jvir.2017.07.015. No abstract available.

PMID:
28841962

Supplemental Content

Loading ...
Support Center